Excessive contraction of Nypertrophic scar and subsequent contracture formation are a formidable problem after thermal injury . A comparison between fibroblasts from Nypertrophic scar and normal skin was made with the use of fibroblast-populated collagen lattices as a measure of cellular generated contractile forces . Hypertrophic scar and normal skin fibroblasts were mixed with soluble tendon collagen and Dulbecco's modified Eagle medium supplemented with 10% serum, and contraction was measured by serial area measurements . Parallel experiments in the presence of transforming growth factor-(3 or anti-transforming growth factor-j3 antibody examined the role of this cytokine on lattice contraction. Transforming growth factor-II activity was measured in an additional set of 10 biopsy specimens . Hypertrophic scar fibroblasts contract lattices at a significantly faster rate than do normal skin fibroblasts . Exogenous transforming growth factor-R increased lattice contraction by normal skin fibroblasts but had little effect on Nypertrophic scar cell-populated lattices . The addition of anti-transforming growth factor-R antibody decreased lattice contraction by both cell types. Transforming growth factor-(3 activity was significantly increased in the Nypertrophic scar biopsy specimens. Excessive scar contraction and post-burn scar contracture result from increased contraction forces generated by Nypertrophic scar cells. This increased contractility appears to be mediated by increased endogenous presence of transforming growth factor-(3. (WOUND REP REG 1995 ;3:185-91) Interactions between cells and their surrounding maofoundly effect cell adhesion, migration, growth, and differentiation .
these cell/matrix interactions during the remodeling phase of wound healing are not fully understood .
A simplified in vitro model to examine some of these interactions is the fibroblast-populated collagen lattice (FPCL) initially described by Bell, Ivarsson, and Merrill14 The FPCL is fabricated from cells, collagen, and serum-containing culture medium. It reduces in size to less than 20°10 of original size during a 1-to 2-week incubation period . '41I-1H Contraction of FPCL is modulated by the cell type composition, cell density, matrix protein composition and concentration, and cytokines ."-"" Because these factors modulate other cell/matrix interactions, it is likely that they would 186 GARNER ET AL . also influence the contraction and reorganization of proteins during wound healing.
After survival from major burn injury, the development of hypertrophic scar, scar contraction, and joint contracture are the major factors limiting complete recovery ." These activities occur during the remodeling phase of burn wound healing and may represent altered cell/matrix interactions, resulting in distortions of normal wound and scar remodeling . Changes in the phenotype of fibroblasts within the scar tissue have been documented with regard to cytokine responses, which may explain the hypocellular and fibrotic nature of these lesions. 32 Similar changes in cell/matrix interactions may explain the excess wound contraction associated with these lesions. The present study examined the activity of fibroblasts derived from hypertrophic scar (HTS) in FPCL contraction to document changes in fibroblast-collagen interaction, which might explain the clinical scar contraction. Because transforming growth factor-(3 (TGF-(3) has been implicated in the phenotypic changes of hypertrophic fibroblasts, the role of endogenous TGF-R in modulating FPCL contraction was also examined .
MATERIALS AND METHODS

Patient characteristics
Hypertrophic skin and normal skin (NS) were excised from patients with hypertrophic scars after burn injury (Table 1) . Full-thickness skin samples were removed from three patients at the time of four reconstructive surgical procedures, 1 to 2 years after burn injury . These scars were red, increasing or stable in size, with symptomatic itching or pain . These lesions were actively contracting at the time of removal, as was evidenced by clinically symptomatic contractures which were not responding to nonoperative therapeutic interventions. An additional skin sample was obtained from a patient 4 years after burn injury, a time period when wound contraction had ceased . Biopsy specimens ranged in size from 20 to 80 cm 2. Normal, uninjured WOUND REPAIR AND REGENERATION APRIL-JUNE 1995 full-thickness skin from adjacent tissue of each patient was also obtained and used as a source of control fibroblasts .
The study protocol for this investigation was approved by the University of Michigan human research review committee (IRB 91-78), thereby ensuring com pliance with the ethical guidelines of the 1975 Declaration of Helsinki .
Tissue biopsy specimens were also obtained from 10 patients (mean age 25 ± 16 years) with clinical HTS 7 to 24 months (mean 17 .2 ± 6.8 months) after ther mal injury to determine the TGF-R production in intact tissues. Full-thickness punch biopsy specimens (6 mm diameter) of HTS and NS were obtained at the time of reconstructive procedures . Biopsy specimens were incubated for 16 to 20 hours in 3 ml MCDB 110 medium (Sigma Chemical Co ., St . Louis, Mo .) with 0.2 mg/ml bovine serum albumin. The conditioned media were then aliquoted and stored at -70°C.
Cell populations
The excised skin samples were treated for 1 to 2 hours with gentamicin 20 mg/L and amphotericin B 2 mg/L . The biopsy specimens were then incubated overnight in 0 .15% trypsin at room temperature . The following morning the epidermis was mechanically disrupted from the underlying dermis by scraping with a scalpel blade and used for other studies. The dermal remnant was rinsed with phosphate-buffered saline solution, minced into 1 to 2 mm pieces, and treated with filter-sterilized crude collagenase 1 mg/ml (Sigma Chemical Co .) for 2 hours at room temperature. After nylon mesh filtration, the cells were plated at 1 to 2 x 106 cells/T-75 flask in MCDB 110 medium (Sigma Chemical Co .) supplemented with 5% fetal bovine serum (FBS). The MCDB 110 medium was modified for use in a 5% CO 2 incubator by the addition of 50 mmol/ L Na 2C0 3, and the pH was adjusted to 7.1 . The cells were grown to confluence at passage 0 and then serially passaged by brief trypsinization with a 1:3 split. These cells resemble typical fibroblasts morphologicallyand synthesize types I and III collagen (data not shown Fibroblost-populated collagen lattices FPCL were manufactured as previously described.2" The collagen used to fabricate FPCL was extracted from rat tail tendon collagen by acetic acid extraction and sodium chloride salt precipitation. The purified collagen was dialyzed, frozen, lyophilized, and stored at 5 mg/ml in 1 mmol/L HCl at 4°C as a viscous solution. Triplicate 0.5 ml samples oftrypsinized HTS or NS fibroblasts at a density of 2 x 10" cells/ml were each added to 1 ml of Dulbecco's modified Eagle medium supplemented with 10%n FBS and 0 .5 ml of collagen solution, rapidly mixed, and immediately poured onto 35 mm diameter petri dishes . The collagen polymerized in less than 90 seconds. The diameter ofeach FPCL was measured daily on the major and minor meridian with a ruler to the nearest 0.5 mm. Lattice area (AREA) was calculated with the formula: AREA = Tc [(major meridian/2) (minor meridian/2)] Cytokine and antibody treatment
To examine the effects ofTGF-P on FPCL contraction, 10 ng/ml (final concentration) of recombinant human TGF-R, (R&D Systems, St . Paul, Minn.) was added to the cell-containing media just before mixing with the collagen solution for fabrication of the HTS or NS fibroblast-populated lattices. Control lattices received the same volume of buffer . The lattices were then allowed to contract, and the rate of contraction was quantified as described previously .
Three additional sets ofFPCL were fabricated with and without a polyclonal anti-TGF-R antibody, which recognizes the TGF-(3 1, TGF-P, and TGF-+-3 isotypes (Genzyme, Cambridge, Mass .). The antibody was added to each gel during fabrication as described here for TGF-R, -resulting in a final concentration of 10 mg/ ml. No further antibody was added to the FPCL during the contraction period . To conserve antibody, we fabricated these lattices in smaller culture dishes measuring 15 mm in diameter and contraction was quantified as described previously for the larger dishes . Nonimmune antibody was not added to control lattices because this procedure has previously been shown to have no effect on the contraction of FPCL .31 TGF-P assay TGF-(3 was quantified by means ofthe mink epithelial cell assay.34 Nonconfluent My 1 Lu mink lung epithe- Contraction data were analyzed in two manners . Statistical comparisons of group FPCL area mean values for each time point were performed by means ofanalysis of variance. When significant differences were found, post hoc testing for multiple comparisons was done with the Tukey method. The relative rates of contraction were compared by means of regressions of the FPCL areas . The data were log-transformed when this comparison resulted in increased linearity. The resulting slopes were compared by means of an analysis to determine parallelism. Significant differences between contraction rates were considered to be present if the resulting T value represented an a value of less than 0.01 .1"
RESULTS
The pertinent clinical characteristics of the patient population from which the HTS and NS cells were derived are summarized in Table 1 . When NS cells from these patients were incorporated into collagen lattices, they caused contraction ofthe lattice at a rate that was initially somewhat slower than that induced by neonatal foreskin fibroblasts (Table 2) . At the end of 8 days, however, the neonatal foreskin and NS fibroblasts had contracted their respective lattices to o and 14% of initial area, respectively . These data confirm that the NS-derived fibroblasts used as a control caused FPCL contraction at rates which are com- Figure 1 Contraction rates of NS and active scar HTS FPCLs . Collagen lattices populated with NS or HTS fibroblasts derived from actively contracting scars (15 to 24 months after injury) were made . At the indicated times after gelation, the lattice areas were measured and expressed as mean ± standard deviation of triplicate experiments (n = 4, cells were from four different patient samples) . HTS fibroblasts induce contraction at a significantly faster rate than NS cells (linear regression of log-transformed slopes, test for parallelism, p < 0.01) . In addition, there is a significantly smaller area of FPCL populated with HTS than with NS cells at each day shown (p< 0 .05, analysis of variance, post hoc testing with the Tukey method) .
parable with those observed with normal foreskin fibroblasts . Moreover, these data show that the differences in contraction by HTS-populated FPCL are not due to changes within the normal cells of these patients .
To determine whether increased contractility of HTS is associated with an increased ability of HTSderived fibroblasts to contract collagen lattices, the lat tice contraction rates of NS and HTS fibroblasts from four cell strains with active young scars (<24-monthold burn scar) were compared . Plotting of lattice area as a functio% of time after gelation showed a significantly increased rate of contraction by HTS versus NS cells for each patient's cells examined, although the magnitude of the difference in contraction rate between HTS and NS cells varied among patients . The results from grouping the data from all four patients during the initial rapid contraction period are shown in Figure 1. Both cell types induce rapid contraction of the lattice during the initial 4 days after lattice formation, resulting in area decreases of 18% and 29% on day 1, 59% and 69% on day 3, and 79% and 87% for day 7 for NS and HTS lattices, respectively . Significant differences in FPCL area for these two cell types persist during a 13-day period for both pooled and individual data . To confirm that the differences in contraction shown in Figure 1 are the result of a change in the rate of contraction rather than only from a change in the con traction rate at day 1, we compared the relative rates (slopes) of contraction for each cell type by means of regression analysis . The area values were log-transformed to increase linearity and compared by means of linear regression . Regressions of the log-transformed areas by day yielded slopes of -0 .259 for NS and -0 .341 for HTS (p < 0.05, t-test for parallelism) . These differences in slope support the conclusion that the rate of contraction induced by HTS is greater.
In contrast to these differences between HTS and NS FPCL contraction rates in donors with young, active scars, fibroblasts derived from one patient with an older and quiescent scar (84-month-old burn scar) did not show any significant difference between contraction induced by NS cells and HTS cells with the use of either method of analysis (data not shown) . Both cell populations contracted FPCL at virtually the same rate for all time points examined .
Because TGF-ß is known to modulate FPCL contraction, the effects of TGF-ß on the contraction of collagen lattices populated with HTS and NS fibro-WOUND REPAIR AND REGENERATION VOL. 3, NO . 2 Figure 3 TGF-P activity in tissue biopsy specimens of NS and HTS . Punch biopsy specimens (6 mmz of normal and hypertrophic skin were incubated in MCDB 110 medium for 18 hours . The resulting conditioned media were assayed for TGF-P content with the use of the mink epithelial cell proliferation assay . In all cases, the TGFj3 content was greater in the HTS-conditioned media (p = 0 .001 . analysis of variance) .
blasts were compared. In the presence of 10 ng/ml of TGF, the rate of contraction increased significantly for NS FPCL (Figure 2 ) (p < 0.01, regression analysis and test for parallelism) . The lattice areas at the last day of contraction, day 6, were similar for the TGF-(3-treated NS FPCL and the HTS FPCL, with or without treatment (p = 0.1.6). In contrast, the untreated NS FPCL were significantly larger (p < 0.01) . These results suggest that increased endogenous production of TGF-P by the HTS fibroblasts may result in increased lattice contraction . To examine this possibility, we determined the effect of specific antibody to TGF-P on FPCL contraction. Treatment of both NS and HTS FPCLs with anti-TGF-ß antibody resulted in significant decreases in the rate of lattice contraction (Table 3 ), supporting our conclusion that TGF-{i mediates the differences in contraction rates between HTS and NS FPCL .
The results of these experiments suggested that increased endogenous release of or increased sensio TGF-P would provide a mechanism for increased contraction induced by HTS cells . Because the original fibroblast cell populations had been fully used in the preceding experiments, TGF-ß production by HTS and NS tissue was determined with the use of an additional series of 10 patients. The mean age ofthese patients was 22 years, and the biopsies were performed a mean of 15 months after their injury, TGF-ß activspecimens was significantly greater from HTS biopsy specimens: 22.5 ± 8.7 ng/ml versus 6.8 ± 5 .4 ng/ml than from NS biopsy specimens (p < 0.001, analysis of variance). Although a marked variability exists between the relative TGF-ß production by each biopsy, in. all cases TGF-P activity was greater e HTS tissue ( Figure 3 ).
a combination ofprocesses includNoun. ing wound contraction, reepithelialization, granulation, and scar deposition . The relative contribution of these factors varies with the individual wound, etiologic status of the wound, and patient. Frequently, healing after burn injury is abnormal and results in excess matrix production, the development of HTS, and subsequent scar contraction . The mechanism whereby normal wound healing becomes, characteristically, deranged and these normal wound healing activities become exaggerated is not fully understood. Previous work has suggested that excess matrix production after thermal injury is due to a phenotypic change of the cells within the wound to cells likely to deposit excess scar . The contraction ofcollagen gels by fibroblasts provides an opportunity to study the mechanisms for increased wound contraction and scar contracture. Contraction of the FPCL reflects remodeling of collagen by wound fibroblasts and the rate of contraction is influenced by the chemical composition of the gel '23,36 the physiologic state ofthe fibroblasts, 2°, 37_42 and cytokines. 17,27.29,43,44 Previous studies of wound contraction after burn injury have implicated changes in matrix protein in its causation. HTS tissues contain altered ratios of type I and III collagen, as well as minor collagens.2°4r ', }`' Because creation of FPCL with type III collagen results in accelerated contraction,23 HTS which contain more ofthis protein are likely to contract more . The findings of this report add intrinsic differences in fibroblast contraction rates and suggest changes in the cytokine environment of the wound as additional mechanisms for the clinical events . These factors together might explain the aggressive contraction diathesis seen in postburn scar contractures .
The influence of TGF-ß on FPCL contraction has been reported previously.27,2 " This relationship is supported in the present study by the ability of TGF-P to 190 GARNER ET AL.
stimulate NS FPCL contraction and by the inhibition of FPCL contraction by anti-TGF-(3 antibody . Furthermore, because antibody treatment reduced the higher contraction rate of HTS FPCL to a level approaching that of NS FPCL, it is likely that the increased contraction induced by HTS fibroblasts is due to enhanced autocrine stimulation by increased levels of endogenous TGF-R production by HTS cells. This hypothesis is supported by the finding of increased release TGF-R by HTS biopsy specimens. Alternatively or additionally, the increased rate of FPCL contraction by HTS cells may be due to an increased sensitivity to the TGF-R in FBS used in the assay media.
Our ability to perform these experiments was limited by the low frequency of patients with these lesions who are surgical candidates during early scar maturation . The cell populations forthese studies were derived from mature, but active, HTS, as defined by time after initial burn injury and clinical symptoms such as ongoing wound contraction, erythema, and itching. One older case was from a significantly older scar which was quiescent, pale, and asymptomatic . These clinical differences between these lesions were reflected in differences between HTS and NS contraction rates ; that is, cells cultured from the quiescent scar were not different from NS fibroblasts isolated from the same donor. This finding suggests an evolution of cell contractile phenotype within the burn wound lesion which characterizes the stages of HTS formation as manifested by clinical signs and symptoms . In addition, the cell populations used for these studies were obtained from clinical specimens of limited tissue, and, therefore, limited numbers of fibroblasts were available for study. Although it is possible to expand fibroblast cell lines greatly, experiments have determined that the phenotype differences between HTS and NS are lost by culture beyond passage 4 (data not shown) . Because the HTS cells grow slowly, serial passage likely results in overgrowth by clones which responds to the tissue culture environment. The results presented in this article reflect the limited number of early passage fibroblasts which are available for study .
Previous investigations of the contractile properties of HTS fibroblasts suggested that these cells were not different from normal dermal fibroblasts in their ability to contract collagen .47 The present findings appear to contradict these previous conclusions. Although the reason for this discrepancy or contradiction is unclear at this time, the variability of contraction rates between patients and the modest difference between HTS and NS fibroblasts suggest an explanation . The former studies did not use patient-matched comparisons between HTS and NS cells. The heterogeneity of individual responses hides the increased contraction shown by the HTS cells. Furthermore, in older inactive or quiescent scars, no significant difference was found in lattice contraction rates. Pooling or grouping results from experiments using cells derived from scars of various ages, and activity may have further diluted the differences between HTS and NS FPCL contraction rates. Finally, the passage number of the fibroblasts used in the previous study was greater than 3. Thus, it is possible that in previous studies the differences documented in these patientmatched populations were lost because of intersubject variability, heterogeneity in scar activity, age, or overexpansion of the cell strains resulting in the loss of a distinct scar phenotype.
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